Word: curing
(lookup in dictionary)
(lookup stats)
Dates: all
Sort By: most recent first
(reverse)
Still, for researchers working toward a cure for diseases like AIDS—even those who have been able to proceed with their projects—the monkey shortage has stands as a major obstacle, costing money and, more importantly, time...
Dirty Pretty Things can't cure the world's ills and doesn't try. It's a movie, not an international treaty. But its dour comic take on misery, and on the strategies people concoct to outsmart it, improves the world of summer films. And you don't have to leave your brain at the door...
...violence being taught in madrasahs. To effect a permanent change of heart in a substantial number of Middle Easterners, a new, inspired and courageous force seems appropriate. The disease of religious fascism urgently requires treatment. Christians have the ideology and determination to risk their lives to offer a cure. Sai Ramananda Whistler, Canada...
...vision didn't immediately play well with biotech investors, many of whom prefer the promise of blowout growth to steady profits. Shares of both companies dropped sharply. Biotech's allure since the benchmark Genentech ipo 23 years ago has been its promise to deliver wonder drugs that will cure feared ailments like cancer and Alzheimer's; compared to that, budgetary discipline seems pretty dull. Yet with an exhaustingly long list of failed products and failed companies in its brief past, the biotech industry each year grows closer to losing sway with the moneymen who fund its research. Even though biotech...
...companies dropped sharply. Who needs another giant drug company pumping out me-too pills, focusing on stuff it already makes and pinching pennies to deliver a steady income? Biotech's allure since the benchmark Genentech IPO 23 years ago has been its promise to deliver wonder drugs that will cure feared ailments like cancer and Alzheimer's. Yet with an exhaustingly long list of failed products and failed companies in its brief past, the industry each year grows closer to losing sway with the moneymen who fund its research. Even though biotech stocks have been moving up this year, among...